Limited coverage criteria – deferasirox

Last updated on March 17, 2025

 

Return to Special Authority drug list 

Generic name

deferasirox

Strength & form

125 mg, 250 mg, 500 mg tablet (dispersible)

90 mg, 180 mg, 360 mg tablet (oral)

Special Authority criteria

Approval period

Treatment of transfusion-dependent conditions where iron chelation therapy is required, according to established criteria*, and when a Special Authority request is submitted by a hematologist

Initial request: 1 year

Renewal request: 1 year

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)

* Click on the Special Authority request form below for full criteria: